INVA
Innoviva, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.33
−0.09%Margins
Gross margin
73.1%
EBITDA margin
185.7%
EBIT margin
36.7%
Net margin
80.6%
FCF margin
42.5%
29.0%
Return on equity
21.0%
Return on assets
10.8%
Return on invested capital
0.25x
Asset turnover
$191.5M
Cash from operations
$8.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026